Skip to content Skip to footer
Rosiglitazone: Benefits, Reviews, Info, Side Effects!
Rx Details
Rosiglitazone
Avandia, Avandamet, Avandaryl
Rosiglitazone
Prescription
Antidiabetic
Drugs
Prescription Only
improves insulin sensitivity, lowers blood sugar levels, helps manage type 2 diabetes, reduces insulin resistance, may improve lipid profiles
Anemia, Edema, Heart Failure, Increased Cholesterol Levels, Increased Risk Of Fractures, Liver Dysfunction, Macular Edema, Weight Gain
Rosiglitazone is a medication used to treat type 2 diabetes. The typical starting dosage for rosiglitazone is usually 4 mg per day, which can be taken as a single dose or divided into two doses of 2 mg each. Depending on the patient’s response and tolerance, the dosage may be increased to 8 mg per day, either as a single dose or divided into two doses. However, it’s important to follow a healthcare provider’s instructions regarding dosage, as individual needs can vary.
Type 2 diabetes mellitus
Rosiglitazone has a mixed safety profile.
Insulin, Metformin, Pioglitazone, Glimepiride
$10.99 – $49.99
$1,000.00

A Synopsis of

Rosiglitazone

Rosiglitazone is a medication commonly used to treat type 2 diabetes. It belongs to a class of drugs known as thiazolidinediones, which work by increasing the body’s sensitivity to insulin, thereby helping to lower blood sugar levels.

This medication is typically prescribed in combination with diet and exercise to help manage blood sugar levels in patients with type 2 diabetes. It is important to follow your healthcare provider’s instructions carefully when taking rosiglitazone, as it is important to monitor blood sugar levels regularly to ensure the medication is working effectively.

As with any medication, rosiglitazone may cause side effects in some individuals. Common side effects may include weight gain, edema (swelling), and an increased risk of heart failure. It is important to discuss any concerns or side effects with your healthcare provider.

It is also important to note that rosiglitazone has been associated with an increased risk of cardiovascular events, such as heart attack and stroke. Due to these risks, the use of rosiglitazone has been restricted in some countries and is not recommended as a first-line treatment for type 2 diabetes.

If you have any questions or concerns about rosiglitazone or any other medications you are taking, please consult with your healthcare provider. They can provide you with personalized guidance and recommendations based on your individual health needs. Remember, managing your diabetes effectively requires a comprehensive approach that includes medication, diet, exercise, and regular monitoring.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN